definiens: means a given Product within the Field that is the subject of a Development Program prior to the Transition Effective Date but excludes in reference to any country any indications for which Marketing Approval has been obtained in any such country ; 1.1.59 means, in respect of any Development Program, the individual appointed as Program Coordinator from among the Team Leaders as set out in Section 6.4 ; 1.1.60 has the meaning set out in Section 6 ; 1.1.61 means, in respect of each party, any information relating to PDT, Photosensitizers, the Products, and such party 's business or other activities that is not generally known to the public or to other persons who are not bound by obligations of confidentiality and : 1 . from which such party derives economic value, actual or potential, from not being generally known ; or 2 . in respect of which such party otherwise has a legitimate interest in maintaining secrecy ; 1.1.62 means [ Patent ' Applidi#~n Nos . 61ji38,O~9 ] and [ § J!~,~2,?4~ ], and any Patents which claim priority thereto ; 1.1.63 means Know - How owned or Controlled by QL T or any of it 's Affiliates as of the Restatement Date relating to the Product and thereafter during the term of this Agreement relating to the Visudyne Product that is necessary or useful for the research, development, manufacture or use or sale of the Visudyne Product in any country in the [COMPANY] Territory . QL T Know - How shall exclude QL T Patents ; 1.1.64 means the Patents listed in Schedule 1.1.64, and any other Patents owned or Controlled by Q L T or any of its Affiliates as of the Restatement Date or thereafter during the Term of this Agreement having claims covering the Visudyne Product, its use, composition, formulation, preparation or manufacture or having claims that are reasonably necessary or useful for the research, development, manufacture, use or commercialization of the Visudyne Product, in all cases excluding the [COMPANY] [ CombinatlQn ] Patents ; [ * 1 Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission . Confidential treatment has been requested with respect to the omitted portions